News Release
FOR IMMEDIATE RELEASE
March 12, 2007

North Shore Man Sentenced on Federal Drug Charges

MAR 12 -- BOSTON, MA - A North Shore man was sentenced today in federal court for his role in a conspiracy to distribute Oxycodone, a prescription pain medication found in brand name pain relievers such as Oxycontin.

June W. Stansbury, Special Agent in Charge of the U.S. Drug Enforcement Administration in New England; United States Attorney Michael J. Sullivan;Mark Dragonetti, Resident Agent in Charge of the Food and Drug Administration’s Office of Criminal Investigations; Douglas A. Bricker, Special Agent in Charge of the U.S. Internal Revenue Service, Criminal Investigation; and Robert L. Champagne, Chief of the Peabody Police Department, announced that CHRISTOPHER ALVITI, 25, of 10 Trask Court, Beverly, Massachusetts, was sentenced by U.S. District Judge Reginald C. Lindsay to 8 years and 1 month in prison, to be followed by 3 years of supervised release. Judge Lindsay also ordered that ALVITI forfeit $63,900 in cash. On June 1, 2005, ALVITI pleaded guilty to an Indictment charging him with Conspiracy to Distribute Oxycodone, Possession of Oxycodone with the Intent to Distribute, and Distribution of Oxycodone.

At the earlier plea hearing, the prosecutor told the Court that between November 2003 and June 2004, ALVITI and co-defendant Richard Gould conspired to distribute Oxycontin in the North Shore area of Massachusetts. Additionally, ALVITI distributed Oxycontin on four occasions to an undercover federal agent. Gould was arrested on June 30, 2004, when he arrived at ALVITI’s Beverly residence to deliver 500 OxyContin tablets to ALVITI. ALVITI had been arrested the day before. Gould was responsible for the possession or distribution of approximately 30,000 illegal Oxycontin tablets.

Gould, 27, formerly of 10 Druid Avenue, Peabody, Massachusetts, pleaded guilty to his role in the conspiracy on January 30, 2006. On September 20, 2006, Judge Lindsay sentenced Gould to 10 years in prison, to be followed by 5 years of supervised release.

The case was investigated by the DEA Tactical Diversion Squad, the DEA Mobile Enforcement Team, the Food and Drug Administration’s Office of Criminal Investigations, the U.S. Internal Revenue Service, Criminal Investigation, the Massachusetts State Police, the Essex County Sheriff’s Department, the Cape Ann Drug Task Force, and the Peabody Police Department’s Drug Unit.